期 |
栏目 |
标题 |
文件 |
卷 1, 编号 1 (2010) |
Articles |
A real way of reducing coronary heart disease mortality in Russia |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 2, 编号 1 (2011) |
Articles |
Preduprezhdenie serdechno-sosudistykhoslozhneniy u patsientov s faktorami riskas pozitsii dokazatel'noy meditsiny |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 2, 编号 1 (2011) |
Articles |
Perspektivy klinicheskogo primeneniyanovoy fiksirovannoy kombinatsii -preparata Ko-Eksforzh v lecheniiarterial'noy gipertonii |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 4, 编号 2 (2013) |
Articles |
Optimization of therapy in a patient with coronary heart disease in clinical practice: proven efficacy of the selective If channel inhibitor ivabradine |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 4, 编号 1 (2013) |
Articles |
Efficacy of a combination of cholesterol absorption and synthesis inhibitors in the correction of hyperlipidemia and dietary fat intolerance in patients with coronary heart disease (ESTHETICS trial) |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 4, 编号 1 (2013) |
Articles |
Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 6, 编号 1 (2015) |
Articles |
Comprehensive medical rehabilitation program after percutaneous coronary intervention for acute myocardial infarction in patients with coronary heart disease and arterial hypertension: efficacy, safety, and the results of remote monitoring |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 6, 编号 3 (2015) |
Articles |
The clinical efficacy of a comprehensive program of rehabilitation after coronary artery bypass grafting in patients with coronary artery disease under outpatient department cardio rehabilitation - III stage of rehabilitation |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 5, 编号 3-4 (2014) |
Articles |
ARB I olmesartan interruption in cardiovascular and cardiorenal continuum: antihypertensive and nephroprotective effects (part 1) |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 6, 编号 1 (2015) |
Articles |
The clinical efficacy of a fixed combination of angiotensin receptor blockers valsartan II with a calcium antagonist amlodipine - drug Exforge® smokers patients with cardiovascular disease and chronic obstructive pulmonary disease |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 6, 编号 3 (2015) |
Articles |
Radiofrequency ablation and antiarrhythmic therapy in the treatment of patients with paroxysmal and persistent atrial fibrillation: clinical effects |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 6, 编号 3 (2015) |
Articles |
Modern approaches to the treatment and long-term management of arterial hypertension in clinical practice. Pharmacological and clinical characteristics of angiotensin II receptor blockers: focus on azilsartan medoxomil. Part II |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 6, 编号 1 (2015) |
Articles |
Blocker, angiotensin II receptor olmesartan to interrupt cardiovascular continuum: vesselsand cardioprotective, anti-atherosclerotic and metabolic pleiotropic effects (part 2) |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 6, 编号 2 (2015) |
Articles |
Modern approaches to the treatment and long-term management of arterial hypertension in clinical practice. Pharmacological and clinical characteristics of angiotensin II receptor blockers: focus on azilsartan medoxomil. Part I |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 7, 编号 1 (2016) |
Articles |
Methodic recommendations Maintaining physical activity of those with limitations in health |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 8, 编号 3 (2017) |
Articles |
Current state and problems of cardio rehabilitation in Russia |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 8, 编号 3 (2017) |
Articles |
Modern opportunities for lifestyle changes and statin therapy in the prevention of cardiovascular diseases |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 8, 编号 4 (2017) |
Articles |
High-intensity therapy: rationale, indications and safety issues. Prospects of rosuvastatin in clinical practice |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 8, 编号 4 (2017) |
Articles |
Basic principles of antiplatelet therapy from the perspective of new recommendations |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 9, 编号 1 (2018) |
Articles |
Clinical efficacy of pitavastatin |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 9, 编号 2 (2018) |
Articles |
New tendencies in the treatment of diabetic and cardiovascular diseases: a view of cardiologists |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 10, 编号 1 (2019) |
Articles |
Adverse effects of statin therapy: real evidence |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 11, 编号 1 (2020) |
Original study articles |
Modern principles of atherogenic dyslipidemia management in special groups of patients |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 11, 编号 4 (2020) |
Editorial |
Rehabilitation after new coronavirus infection (COVID-19): principles and approaches |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 12, 编号 2 (2021) |
Consensus |
Novel сoronavirus infectious disease COVID-19: features of comprehensive cardiac and respiratory rehabilitation |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 12, 编号 2 (2021) |
Reviews |
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 12, 编号 4 (2021) |
Reviews |
Type 2 diabetes mellitus and chronic heart failure: new treatment strategies |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 13, 编号 1 (2022) |
Reviews |
Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 13, 编号 1 (2022) |
Reviews |
Current guidelines for β-adrenoblockers use in cardiovascular diseases: focus on metoprolol succinate CR/XL: A review |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 14, 编号 3 (2023) |
Original study articles |
Long-term effects of a home exercise program in patients with acute myocardial infarction and percutaneous coronary intervention: prospective observational study |
![PDF](/img/labels/pdf.png) (Rus)
|